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Introduction: The clinical presentation of eosinophilic myocarditis may vary from asymptomatic to the
manifestation of severe symptoms, including cardiac tamponade and arrhythmias. In pregnant patients with this
condition, drugs must be used cautiously up to approximately the 4th month of pregnancy because drug use
should be limited during the period of fetal organogenesis.
Case presentation: A 30-year-old Asian woman at 14 weeks of pregnancy with progressive malaise was hospitalized.
The electrocardiogram revealed ST elevation and low QRS voltage. Echocardiography revealed massive pericardial
effusion and myocardial swelling. A laboratory examination revealed an increase in her white blood cell count, with a
predominance of neutrophils. Pericardial drainage was performed for relief of the cardiac tamponade. The pericardial
effusion revealed an abundance of eosinophils. Subsequently, the peripheral blood eosinophil count began to rise, and
the patient was clinically diagnosed with eosinophilic myopericarditis. The patient’s condition improved rapidly
following the initiation of prednisolone treatment, and she finally delivered a full-term normal infant.
Conclusions: A patient with clinically suspected myopericarditis in the early stage of pregnancy who improved rapidly
with pericardial drainage and prednisolone therapy, and successfully delivered a normal full-term infant; the diagnosis
was made in the early stage of the disease, based on the detection of an abundance of eosinophils in the pericardial
effusion preceding the subsequent development of peripheral blood eosinophilia.
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Eosinophilic myocarditis is characterized by myocarditis as-
sociated with marked eosinophilic infiltration of the myo-
cardium and peripheral blood eosinophilia. In addition, the
clinical presentation of myocarditis may vary from asymp-
tomatic to the manifestation of severe symptoms [1]. Some
patients develop cardiac tamponade due to the associated
pericarditis, whereas others may show rapid progression of
myocardial necrosis, manifesting as fatal arrhythmias, car-
diac arrest, or a clinical state necessitating mechanical as-
sistance for the maintenance of circulation. The mortality* Correspondence: hmorimoto2002@yahoo.co.jp
1Department of Internal Medicine, Matsushita Memorial Hospital, 5-55,
Sotojimacho, Moriguchi-shi, Osaka 570-8540, Japan
Full list of author information is available at the end of the article
© 2013 Kasamatsu et al.; licensee BioMed Cen
Creative Commons Attribution License (http:/
distribution, and reproduction in any mediumassociated with the acute stage of this disease is reported to
be 7% [2].
In pregnant patients with this condition, drugs must be
used cautiously up to approximately the 4th month of preg-
nancy (the period of fetal organogenesis) because drug use
should be limited during this period [3]. We encountered a
patient with acute clinically suspected myopericarditis who
presented, at 14 weeks of pregnancy, with cardiac tampon-
ade and marked peripheral blood eosinophilia. Here we
present this case.Case presentation
A 30-year-old Asian woman who was 14 weeks and 5 days
pregnant (gravida, 1; para, 0) presented to us with general-
ized malaise and facial edema in June 2007. She had notral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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was a non-smoker and gave no history of drug abuse or
eating raw food. She visited a local medical clinic, where a
routine blood examination revealed leukocytosis. As the
malaise worsened, the patient was brought by ambulance
to our hospital for further management. Analysis of her
vaginal secretions and ultrasonography of the fetus
conducted by an obstetrician/gynecologist revealed no
major abnormalities. Pregnancy-induced hypertension was
ruled out at that time. Therefore, the patient was referred
to the Department of Cardiovascular Medicine of our
hospital.
The findings on physical examination at admission
were: height, 155cm; weight, 68.2kg; blood pressure,
90/70mmHg. Sinus tachycardia (heart rate, 140/minute;
regular beats) was noted, with a body temperature of
36.7°C. The peripheral arterial oxygen saturation was
96% on room air. There were no evident cutaneous
eruptions. Jugular venous distention, puffiness of the
eyelids and pitting edema of the extremities were
noted. Although no significant murmur and rale could
be appreciated on chest examination, a pericardial rub
was heard.
Chest radiography (Figure 1) revealed cardiomegaly (car-
diothoracic ratio, 55%), reduced radiolucency of both lung
fields, and prominent pulmonary vascular markings. An
electrocardiogram obtained during the first visit (Figure 2)
showed sinus tachycardia (heart rate, 130/minute), right
axis deviation, QS pattern in leads I and aVL, ST elevationFigure 1 Chest radiography on admission. Taken in the
semi-sitting position. Shows cardiomegaly (cardiothoracic ratio, 55%),
reduced radiolucency of both lung fields, and prominent pulmonary
vascular markings.in leads II, III, aVf, and V3 to V6, and a low QRS voltage
in the extremity leads.
Transthoracic echocardiography (performed via a para-
thoracic approach) on admission revealed massive pericar-
dial effusion with evidence of collapse of the right atrium
and ventricle. The left ventricular wall showed almost full-
circumferential thickening (15mm) and diffusely dimin-
ished wall motion (ejection fraction 45%, Figure 3). Other
abnormalities noted included left ventricular diastolic dys-
function (left ventricular inflow waveform, E:A ratio 0.9),
dilatation of the inferior vena cava (diameter, 19mm), tri-
cuspid regurgitation (pressure gradient, 25mmHg), and
mild pulmonary hypertension (estimated pulmonary arter-
ial pressure, 35mmHg).
The laboratory test data on admission were as follows:
peripheral blood white blood cell count, 21700/mm3 (seg-
mented neutrophils 77%, lymphocytes 17%, eosinophils
1%, mononucleated cells 5%); serum C-reactive protein,
2.3mg/dL; serum brain natriuretic peptide (BNP), 610pg/mL;
serum creatine kinase (CK)-MM and CK-MB, 202 and
22mg/dL, respectively; test for troponin T, positive. Anti-
parasitic antibodies and autoantibodies, including antinu-
clear antibody, were negative.
After admission to the intensive care unit under the clin-
ical diagnosis of acute myopericarditis, she was treated with
oxygen supplementation and diuretic therapy. In addition,
use of the uterine relaxant isoxsuprine was initiated in con-
sultation with an obstetrician, because she was 14 weeks
pregnant. Myocardial biopsy was skipped in order to avoid
exposure of the patient and the fetus to radiation and stress.
Soon after admission, however, the systolic blood pressure
dropped to the order of 70mmHg. Therefore, pericardial
drainage was performed for relief of the cardiac tamponade;
a yellowish transparent fluid was aspirated at a volume of
about 300mL, and the systolic blood pressure rose to about
100mmHg. Thereafter, intravenous antibiotics were initi-
ated. The pericardial effusion had a high specific gravity
and was exudative in nature, containing a large number of
eosinophils (69%). In addition, hematological examination
on hospital day 3 revealed a slight increase in the absolute
peripheral blood eosinophil count and elevation of the
serum immunoglobulin E level to 1766IU/mL. She was
clinically diagnosed with eosinophilic myopericarditis, and
the patient was started on oral prednisolone (PSL) therapy
at the dose of 30mg/day (0.5mg/kg per day), taking the
risks of prolonged decrease in maternal cardiac function
and the adverse effects of PSL into account. The patient
showed dramatic improvement of the clinical symptoms
following the start of the treatment with PSL. The periph-
eral blood eosinophil count, which had temporarily
exceeded 5000/mm3, decreased again on hospital day 14,
accompanied by a return of the cardiac function to normal
(ejection fraction, 60% and left-ventricular wall thickness,
11mm). BNP and CK-MB levels improved to normal range
Figure 2 Electrocardiogram taken at the first visit. Sinus tachycardia (heart rate, 140/minute), ST elevation in leads I, II, III, aVL, aVf, and V3 to
V6, and low QRS voltage in the limb leads.
Figure 3 Echocardiogram on admission. Long axial view (left) and short axial view (right) obtained via a parathoracic approach. Almost
full-circumferential thickening of the left ventricular wall and massive pericardial effusion are noted.
Kasamatsu et al. Journal of Medical Case Reports 2013, 7:129 Page 3 of 5
http://www.jmedicalcasereports.com/content/7/1/129
Kasamatsu et al. Journal of Medical Case Reports 2013, 7:129 Page 4 of 5
http://www.jmedicalcasereports.com/content/7/1/129on hospital day 20. The PSL dose was reduced to 20mg, and
the patient was discharged from the hospital in a stable clin-
ical condition on hospital day 22 and followed up thereafter
as an out-patient. Measurement of viral antibody titers
(coxsackievirus, echovirus, and so on) in paired sera revealed
no significant elevation of the titers of any of the antibodies.
During the out-patient management, the PSL dose was
gradually reduced, without relapse of symptoms. On day
63 after the diagnosis of the disease, oral PSL therapy was
discontinued. Although the patient had to be hospitalized
for approximately 1 week because she temporarily suffered
from pregnancy-induced hypertension, the clinical course
was favorable overall, and the patient delivered a healthy
baby at the gestational age of 41 weeks.
Discussion
Eosinophilic myopericarditis is believed to be caused by
cytotoxic substances, such as eosinophil cationic protein
and major basic protein present in the granules of eosino-
phils [4]. The diagnosis is established by myocardial biopsy.
Eosinophilic myopericarditis may be divided etiologically
into three types: (1) parasitic infestation, (2) cardiomyop-
athy due to chronic eosinophilia as a component of the
hypereosinophilic syndrome or Churg–Strauss syndrome
and (3) transient and temporary acute myopericarditis due
to hypersensitivity which is generally caused by exposure to
irritants such as drugs and allergens [1,5,6]. In our patient,
although we can rule out parasitic infestation and drug re-
action, the role of pregnancy in the pathogenesis of this dis-
ease could not be ruled out. According to our literature
search, we could not find a relationship between eosino-
philia and pregnancy. However, the course of the disease
was transient and favorable; thus, the disease was thought
to be the acute hypersensitivity type. The clinical course of
acute eosinophilic myocarditis, with the exception of ful-
minant type, is generally transient and its prognosis is good.
However, a few cases had major basic protein expression in
myocardial biopsy specimens longitudinally after the onset
of the disease, therefore, we should cautiously follow up
even after alleviation of the acute-phase inflammation [2].
Abundant accumulation of eosinophils in the target
organ was noted on admission, although no significant
increase in the peripheral blood eosinophil count was
noted. One possible explanation for the accumulation of
eosinophils in the target organ that has been proposed is
that some stimuli induce migration of eosinophils to-
wards the target organ, but the formation of eosinophils
in the bone marrow cannot compensate for this change,
resulting in a transient paradoxic eosinopenia. Later, eo-
sinophil formation in the bone marrow continues even
after tissue infiltration by eosinophils has decreased,
resulting in peripheral blood eosinophilia [7]. Although
inhalation of the antigen might cause the accumulation
of eosinophilic leukocytes via inteleukin-5 in lungdisease [8], the precise mechanism of accumulation of
eosinophils in the myocardium preceding the increase in
the peripheral blood eosinophil count remains unknown.
The symptoms of eosinophilic myocarditis are akin to
those of viral myocarditis. In the early stages of eosino-
philic myocarditis, peripheral blood eosinophilia is some-
times absent [9]. Therefore, it is desirable to check the
blood cell counts at intervals of 2 to 3 days when myocar-
ditis is suspected.
Steroids have been shown to be effective in the treat-
ment of eosinophilic myocarditis [1,5]. In regard to the
use of steroids during pregnancy, however, animal studies
have shown an increased death rate of the fetus following
administration of high PSL doses and an increased risk for
the development of cleft lip following the use of PSL, even
at ordinary doses, during the first trimester of pregnancy
[3,10]. Steroid therapy is certainly acceptable in patients
with severe disease, as in the case of our patient who
presented with cardiac tamponade, because maternal low
blood pressure caused by cardiac dysfunction and
hypercytokinemia can adversely affect the continuation of
pregnancy and the mother’s prognosis. However, unex-
pected outcomes may be encountered with the use of ste-
roids and cardiac biopsy using X-ray during pregnancy
may lead to unexpected outcomes, since adequate clinical
data related to its use during pregnancy is still not avail-
able [3]. A typical myopericarditis pattern on T2 and late
gadolinium-enhanced sequences of cardiac magnetic res-
onance imaging can be useful in the case of pregnancy
[11]. Both patients and their family members tend to be
anxious about the use of these drugs, especially during
pregnancy. Therefore, we should explain the risks and
benefits of this therapy to patients and their family mem-
bers prior to the start of this treatment.
In a previous report of a patient with eosinophilic myo-
carditis developing at 24 weeks of pregnancy, thickening of
the ventricular septum was observed, with subsequent in-
crease in the peripheral blood eosinophil count, which
clinched the diagnosis. The disease was mild in that case,
and resolved in response to symptomatic therapy with ver-
apamil, furosemide, and so on [12]. In our present patient,
the disease was severe, and the patient presented with car-
diac tamponade. Treatment was difficult because only a
limited number of drugs could be used because the patient
was in the early stages of pregnancy. However, appropriate
pericardial drainage and PSL therapy resulted in early alle-
viation of the condition, which allowed continuation of the
pregnancy and successful child delivery. This is a type of
case as yet unrepresented the literature, which may there-
fore prove clinically informative.
Conclusions
We encountered a patient with myopericarditis in the
early stage of pregnancy who improved rapidly with
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livered a normal full-term infant; the diagnosis was made
in the early stage of the disease, based on the detection of
an abundance of eosinophils in the pericardial effusion
preceding the subsequent development of peripheral
blood eosinophilia.
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